antiretroviral therapy in the malawi defence force access, treatment outcomes and impact on mortality马拉维国防军访问抗逆转录病毒治疗,治疗结果和对死亡率的影响.pdfVIP

Antiretroviral Therapy in the Malawi Defence Force: Access, Treatment Outcomes and Impact on Mortality 1 2 3,4 3 5 6 7 Alfred C. Banda , Simon D. Makombe , Andreas Jahn , Hannock Tweya , Stuart Chuka , Joseph Kwong-Leung Yu , Bethany Hedt , Ralf 3 2 2,8 2 2,9,10 Weigel , Amon Nkhata , Erik J. Schouten , Kelita Kamoto , Anthony D. Harries * 1 Malawi Defence Force, Medical Department, Lilongwe, Malawi, 2 HIV Unit, Ministry of Health, Lilongwe, Malawi, 3 Lighthouse Trust, Lilongwe, Malawi, 4 International Training and Education Center on HIV, Seattle, Washington, United States of America, 5 Malawi Business Coalition against AIDS, Blantyre, Malawi, 6 Taiwan Medical Mission, Mzuzu Central Hospital, Mzuzu, Malawi, 7 Harvard School of Public Health, Boston, Massachusetts, United States of America, 8 Management Sciences for Health, Lilongwe, Malawi, 9 Family Health International, Malawi Country Office, Lilongwe, Malawi, 10 London School of Hygiene and Tropical Medicine, London, United Kingdom Background. HIV/AIDS affects all sectors of the population and the defence forces are not exempt. A national survey was conducted in all public and private sectors in Malawi that provide antiretroviral therapy (ART) to determine the uptake of ART by army personnel, their outcomes while on treatment, and the impact of ART on mortality in the Malawi Defence Force. Methodology/Principal Findings. A retrospective cohort analysis was carried out, collecting data on access and retention on treatment from all 103 public and 38 private sector ART clinics in Malawi, using standardised patient master cards and clinic registers